Logo image of TXMD

THERAPEUTICSMD INC (TXMD) Stock Analyst Earnings Estimates

NASDAQ:TXMD - Nasdaq - US88338N2062 - Common Stock - Currency: USD

1.3  +0.29 (+28.71%)

After market: 1.22 -0.08 (-6.15%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
TXMD revenue by date.TXMD revenue by date.
2.57M
-96.04%
69.96M
2,622.18%
1.302M
-98.14%
9.18M
605.07%
9.282M
1.11%
9.486M
2.20%
9.69M
2.15%
9.894M
2.11%
10.098M
2.06%
10.2M
1.01%
EBITDA
YoY % growth
TXMD ebitda by date.TXMD ebitda by date.
-78.84M
48.97%
11.85M
115.03%
-7.601M
-164.14%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
TXMD ebit by date.TXMD ebit by date.
-79.58M
48.84%
10.66M
113.40%
-8.523M
-179.95%
4.794M
156.25%
4.998M
4.26%
2.448M
-51.02%
2.754M
12.50%
3.06M
11.11%
3.264M
6.67%
3.468M
6.25%
Operating Margin
TXMD operating margin by date.TXMD operating margin by date.
-3,096.50%15.24%-654.61%52.22%53.85%25.81%28.42%30.93%32.32%34.00%
EPS
YoY % growth
TXMD eps by date.TXMD eps by date.
-21.50
35.82%
11.80
154.88%
N/A
-103.28%
0.36
192.11%
0.360.17
-51.43%
0.19
11.76%
0.20
5.26%
0.22
10.00%
0.23
4.55%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth

-100.25%
-0.02%
Q3 2023
Q2Q % growth
-0.13
95.85%
-0.05-0.08-154.90%
Q2 2023
Q2Q % growth
-0.24
-101.94%
-0.07-0.17-236.13%
Q1 2023
Q2Q % growth
-0.37
93.50%
0.06-0.43-704.58%
Q4 2022
Q2Q % growth
8.23
264.60%
-1.139.36826.90%
Q3 2022
Q2Q % growth
-3.13
43.09%
-0.58-2.55-438.36%
Q2 2022
Q2Q % growth
12.39
325.27%
-3.1015.49499.57%
Q1 2022
Q2Q % growth
-5.69
-3.45%
-4.08-1.61-39.46%
Q4 2021
Q2Q % growth
-5.00
33.33%
-3.91-1.09-27.87%
Q3 2021
Q2Q % growth
-5.50
8.33%
-5.10-0.40-7.84%
Q2 2021
Q2Q % growth
-5.50
42.11%
-5.610.111.96%
Q1 2021
Q2Q % growth
-5.50
47.62%
-5.920.427.03%
Q4 2020
Q2Q % growth
-7.50
21.05%
-5.36-2.14-40.06%
Q3 2020
Q2Q % growth
-6.00
7.69%
-6.970.9713.92%
Q2 2020
Q2Q % growth
-9.50 -8.76-0.74-8.48%
Q1 2020
Q2Q % growth
-10.50
-31.25%
-9.56-0.94-9.80%
Q4 2019
Q2Q % growth
-9.50 -9.540.040.45%
Q3 2019
Q2Q % growth
-6.50 -9.783.2833.50%
Q2 2019
Q2Q % growth
-9.50 -8.79-0.71-8.03%
Q1 2019
Q2Q % growth
-8.00 -8.500.505.88%
TXMD Yearly EPS VS EstimatesTXMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 10 -10 -20 -30
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
547K
1,194.00%
%
Q2 2024
Q2Q % growth
234K
-46.45%
%
Q1 2024
Q2Q % growth
313K
-24.76%
%
Q4 2023
Q2Q % growth
502K
-56.35%
612K-110K-17.97%
Q3 2023
Q2Q % growth
-50K
-114.29%
510K-560K-109.80%
Q2 2023
Q2Q % growth
437K
24.86%
510K-73K-14.31%
Q1 2023
Q2Q % growth
416K
-40.57%
1.734M-1.318M-76.01%
Q4 2022
Q2Q % growth
1.15M
101.75%
24.276M-23.126M-95.26%
Q3 2022
Q2Q % growth
350K
-98.62%
27.336M-26.986M-98.72%
Q2 2022
Q2Q % growth
350K
-98.48%
23.664M-23.314M-98.52%
Q1 2022
Q2Q % growth
700K
-96.48%
18.314M-17.614M-96.18%
Q4 2021
Q2Q % growth
-65.7M
-390.97%
29.977M-95.677M-319.17%
Q3 2021
Q2Q % growth
25.41M
31.39%
26.389M-979K-3.71%
Q2 2021
Q2Q % growth
23M
114.95%
21.792M1.208M5.54%
Q1 2021
Q2Q % growth
19.87M
62.20%
20.163M-293K-1.45%
Q4 2020
Q2Q % growth
22.58M
42.01%
22.326M254K1.14%
Q3 2020
Q2Q % growth
19.34M
-18.47%
15.637M3.703M23.68%
Q2 2020
Q2Q % growth
10.7M
75.99%
10.584M116K1.10%
Q1 2020
Q2Q % growth
12.25M
210.13%
11.525M725K6.29%
Q4 2019
Q2Q % growth
15.9M 13.084M2.816M21.52%
Q3 2019
Q2Q % growth
23.72M 8.303M15.417M185.68%
Q2 2019
Q2Q % growth
6.08M 5.222M858K16.43%
Q1 2019
Q2Q % growth
3.95M 6.008M-2.058M-34.25%
TXMD Yearly Revenue VS EstimatesTXMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 0%
RevenueN/A N/A 0% 0%